Bold takeaway: scorpion venom does more than just harm—it activates the blood-clotting system in surprising ways, revealing new avenues for medical science.
A University of Queensland team has uncovered an extra biochemical sting in the venom of a deadly scorpion that could steer future medical tests and treatments. Led by Professor Bryan Fry and PhD candidate Sam Campbell from UQ’s School of the Environment, the researchers examined how fat-tailed scorpion venom affects blood clotting.
The Androctonus genus, found in the Middle East and North Africa, carries a neurotoxic venom capable of overwhelming the nervous system and potentially causing heart failure. The new study shows an additional danger: the venom can trigger rapid clotting in human blood.
Ms. Campbell explained that clinical reports had long hinted at abnormal clotting in some scorpion sting patients, but the mechanism remained unclear until now. By introducing the venoms to human plasma, the team observed accelerated clotting and then traced the molecular steps driving this procoagulant effect. The discovery not only explains a clinical puzzle but also opens a fresh line of inquiry into venom evolution and medical impact.
Key findings show Androctonus venoms activate major clotting factors—especially Factors VII and X—and that this process relies on Factor V being in its activated form.
The researchers also explored antidotes and found that a commonly used antivenom for fat-tailed scorpion stings did not counteract the procoagulant activity.
Campbell hopes this work will improve clinical care by alerting doctors to monitor and test for abnormal clotting after scorpion envenomation. He noted that while the current antivenom effectively neutralizes neurotoxic effects, it did not affect the venom’s clotting action. Importantly, two small-molecule metalloprotease inhibitors, marimastat and prinomastat, neutralized the procoagulant effects in their tests. This not only confirms the enzymatic target but also points to potential adjunct therapies that could complement antivenom, especially when venom effects aren’t fully countered.
Fry emphasized the translational potential: venoms hide highly sophisticated molecules that can inform diagnostic tools for blood disorders or lead to new treatments. Uncovering a novel mechanism reveals molecular tools that can spark drug discovery, even if final medicines diverge from venom components. The researchers note that some scorpions can hijack central elements of the blood-clotting cascade in ways reminiscent of certain snake venoms, and these insights might save lives by improving blood management during surgery or after injury.
The study is published in Biochimie. doi: 10.1016/j.biochi.2026.02.018.
